Related Experiment Video
Updated: Sep 3, 2025
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.9K
Emerging Genotype-Phenotype Associations in Dilated Cardiomyopathy
Joyce N Njoroge1,2, Jennifer C Mangena2, Chiaka Aribeana2
1Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, CA, 94103, USA.
Current Cardiology Reports
|July 28, 2022
Summary
Understanding genetic causes of inherited dilated cardiomyopathy (DCM) improves patient care. New genotype-phenotype insights help assess risks and tailor treatments for this serious heart condition.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Inherited dilated cardiomyopathy (DCM) presents a significant, potentially underestimated, disease burden.
- Therapeutic strategies for DCM can be greatly enhanced by targeting specific genetic origins.
- Advances in understanding genetic factors are crucial for improving patient outcomes.
Purpose of the Study:
- To review recent progress in identifying genotype-phenotype relationships in inherited DCM.
- To explore how these relationships can refine clinical management and patient care.
- To highlight novel genetic discoveries and their clinical implications for DCM.
Main Methods:
- Literature review of recent scientific publications on inherited DCM.
- Analysis of novel gene discoveries and their association with DCM phenotypes.
- Examination of variant-environment interactions in the context of DCM.
Main Results:
- Several novel DCM-associated genes and their specific outcomes have been identified.
- New genotype-phenotype correlations aid in assessing sudden cardiac death risk.
- FLNC, LMNA, DSP, RBM20, and TTN variants are highlighted for their prognostic significance and interactions with environmental factors.
- Understanding variant-environment interactions is key for toxin-mediated DCM.
Conclusions:
- Improved diagnostic accuracy and prognostic capabilities in DCM are emerging.
- Future research should focus on novel gene identification and understanding complex genetic and environmental interactions.
- Personalized therapeutic approaches based on genetic profiles hold promise for inherited DCM management.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
43
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43
01:30Cardiomyopathy II: Dilated Cardiomyopathy
20
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20
01:25Cardiomyopathy I: Introduction and Classification
47
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
47
01:29Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
23
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23
01:29Heart Failure II: Pathophysiology
31
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31